相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
Banumathi K. Cole et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Juan Pablo Arab et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis
Ming Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics
Sabine U. Vorrink et al.
FASEB JOURNAL (2017)
Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development
Matthew D. Davidson et al.
INTEGRATIVE BIOLOGY (2017)
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
Samir Softic et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease
Karim Gariani et al.
JOURNAL OF HEPATOLOGY (2017)
Lipid droplets and liver disease: from basic biology to clinical implications
Nina L. Gluchowski et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Three-dimensional perfused human in vitro model of nonalcoholic fatty liver disease
Tomasz Kostrzewski et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Obesity
Pedro Gonzalez-Muniesa et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance
Noelia Martinez-Sanchez et al.
CELL METABOLISM (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Varman T. Samuel et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid
Noortje Ijssennagger et al.
JOURNAL OF HEPATOLOGY (2016)
The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis
Mark A. Herman et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes
Matthew D. Davidson et al.
SCIENTIFIC REPORTS (2016)
Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device
Manuele Gori et al.
PLOS ONE (2016)
Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability
Caifeng Yan et al.
SCIENTIFIC REPORTS (2016)
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease
Catherine C. Bell et al.
SCIENTIFIC REPORTS (2016)
Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Delilah F. G. Hendriks et al.
SCIENTIFIC REPORTS (2016)
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis
Ryan E. Feaver et al.
JCI INSIGHT (2016)
Challenges and Opportunities in Drug and Biomarker Development for Nonalcoholic Steatohepatitis: Findings and Recommendations From an American Association for the Study of Liver Diseases-US Food and Drug Administration Joint Workshop
Arun J. Sanyal et al.
HEPATOLOGY (2015)
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question
Letitia Adela Maria Streba et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
Paola Dongiovanni et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Nonalcoholic Steatohepatitis: A Search for Factual Animal Models
Sheila Cristina L. Sanches et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Nonalcoholic fatty liver disease
Elizabeth M. Brunt et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease
Mariana Verdelho Machado et al.
PLOS ONE (2015)
nature INSIGHT LIPIDS IN HEALTH AND DISEASE
Joshua Finkelstein et al.
NATURE (2014)
Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study
Juanwen Zhang et al.
SCIENTIFIC REPORTS (2014)
In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
Giridhar Kanuri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The burden of liver disease in Europe: A review of available epidemiological data
Martin Blachier et al.
JOURNAL OF HEPATOLOGY (2013)
Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
Melania Gaggini et al.
NUTRIENTS (2013)
Fat Depots, Free Fatty Acids, and Dyslipidemia
Jon O. Ebbert et al.
NUTRIENTS (2013)
Profiling the Impact of Medium Formulation on Morphology and Functionality of Primary Hepatocytes in vitro
Leonard J. Nelson et al.
SCIENTIFIC REPORTS (2013)
Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Rui M. Tostoes et al.
HEPATOLOGY (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Physiologic action of glucagon on liver glucose metabolism
C. J. Ramnanan et al.
DIABETES OBESITY & METABOLISM (2011)
Diacylglycerol-mediated insulin resistance
Derek M. Erion et al.
NATURE MEDICINE (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dietary fructose and the metabolic syndrome
Abigale Miller et al.
CURRENT OPINION IN GASTROENTEROLOGY (2008)
Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice
Alicia G. Gomez-Valades et al.
DIABETES (2008)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
The role of GSK3 in glucose homeostasis and the development of insulin resistance
Jongsoon Lee et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Treatment of non-alcoholic fatty liver disease
LA Adams et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1
M Karlgren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Metformin reverses fatty liver disease in obese, leptin-deficient mice
HZ Lin et al.
NATURE MEDICINE (2000)
分享论文
